AFIB icon

Acutus Medical
AFIB

Delisted

AFIB was delisted on the 9th of May, 2024.

 

About: Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.

Employees: 233

Financial journalist opinion

Neutral
GlobeNewsWire
2 weeks ago
Acutus Medical Announces Operational Downsizing
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing.
Acutus Medical Announces Operational Downsizing
Neutral
GlobeNewsWire
1 month ago
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024.
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
Neutral
GlobeNewsWire
4 months ago
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024.
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
Neutral
GlobeNewsWire
7 months ago
Acutus Medical Reports First Quarter 2024 Financial Results
CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024.
Acutus Medical Reports First Quarter 2024 Financial Results
Negative
InvestorPlace
7 months ago
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
Acutus Medical (NASDAQ: AFIB ) stock is falling hard on Monday as investors prepare for the arrhythmias tool development company's delisting later this week. AFIB stock is being delisted due to its inability to reach the minimum bid price of $1 per share on the Nasdaq Exchange.
Why Is Acutus Medical (AFIB) Stock Down 41% Today?
Neutral
GlobeNewsWire
8 months ago
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023.
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Positive
Benzinga
1 year ago
Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX)
Charts implemented using Lightweight Charts™